Disease | rheumatoid arthritis |
Comorbidity | C0553662|juvenile idiopathic arthritis |
Sentences | 1 |
PubMedID- 26538839 | Tocilizumab is a humanized il-6 receptor monoclonal antibody [73], approved by the fda and ema for use in moderately to severely active rheumatoid arthritis, for children with polyarticular juvenile idiopathic arthritis and for the treatment of systemic juvenile idiopathic arthritis (sjia). |
Page: 1